Printer Friendly

DATASCOPE CORP. REPORTS SALE OF ANGIOPLASTY BUSINESS

 MONTVALE, N.J., June 8 /PRNewswire/ -- Datascope Corp. (NASDAQ: DSCP) today announced that it has sold the assets of its angioplasty division to Boston Scientific Corporation (NYSE: BSX). Under the terms of the sale, Datascope received an initial payment that will result in non-recurring pre-tax income in the fourth quarter of $3.3 million, or $0.15 per share after taxes, after deducting non- recurring expenses.
 Datascope will also receive additional payments contingent upon certain events, including Boston Scientific's obtaining U.S. Food and Drug Administration approval to market certain products. Datascope had suspended operations of its angioplasty division in July 1992.
 Datascope Corp. is a manufacturer of proprietary products for clinical health care markets in interventional cardiology, anesthesiology, and cardiovascular and vascular surgery.
 -0- 6/8/93
 /CONTACT: Murray Pitkowsky, senior vice president of Datascope, 201-307-5504/
 (DSCP BSX)


CO: Datascope Corp.; Boston Scientific Corporation ST: New Jersey IN: MTC SU:

GK-OS -- NY078 -- 6708 06/08/93 16:50 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 8, 1993
Words:160
Previous Article:PEABODY COAL COMPANY FILES SUIT OVER STRIKES, WORK SLOWDOWNS BY UMWA
Next Article:IMC FERTILIZER GROUP AMENDS 1992 ANNUAL REPORT
Topics:


Related Articles
DATASCOPE REPORTS 42 PERCENT RISE IN SECOND QUARTER NET
DATASCOPE TO SUSPEND ANGIOPLASTY OPERATIONS
DATASCOPE REPORTS STRONG OPERATING RESULTS FOR FISCAL 1992
BOSTON SCIENTIFIC CORPORATION ANNOUNCES ACQUISITION OF DATASCOPE CORONARY ANGIOPLASTY PRODUCT LINE
DATASCOPE REPORTS FISCAL 1993 RESULTS
/FIRST AND FINAL ADD -- NY077 -- DATASCOPE EARNINGS/
DATASCOPE RECEIVES APPROVAL OF VASOSEAL FROM FDA
DATASCOPE LAUNCHES VASOSEAL AT AHA
Datascope Announces Lifting Of FDA's Application Integrity Policy (AIP) Restrictions

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters